FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028557462> ?p ?o ?g. }

• W2028557462 abstract "The first-line treatment in chronic myeloid leukemia (CML), imatinib, has been shown to decrease the production of amyloid-β (Aβ) in vitro and in animal studies. However, whether imatinib has this effect in humans is not known.Plasma levels of Aβ42 were analyzed in sequential samples from CML patients treated with imatinib (n=51). The effect of imatinib on Aβ production was also investigated in human embryonic kidney 293 (HEK293) cells overexpressing the amyloid precursor protein (APP) with the Swedish mutation, in mouse primary cortical neurons and in human Down syndrome embryonic stem-cell-derived cortical neurons.Twelve months of imatinib treatment did not lower plasma Aβ42 levels in CML patients, and imatinib treatment did not lead to less Aβ42 production in any of the in vitro models whereas β- and γ-secretase inhibitors did.These data question the previously described role of imatinib in inhibiting amyloidogenic APP processing and as a drug candidate for AD." @default.
• W2028557462 created "2016-06-24" @default.
• W2028557462 creator A5020185605 @default.
• W2028557462 creator A5041986125 @default.
• W2028557462 creator A5063586602 @default.
• W2028557462 creator A5068342352 @default.
• W2028557462 creator A5068394264 @default.
• W2028557462 creator A5079181777 @default.
• W2028557462 creator A5085816874 @default.
• W2028557462 creator A5086843415 @default.
• W2028557462 creator A5091785793 @default.
• W2028557462 date "2013-12-12" @default.
• W2028557462 modified "2023-10-17" @default.
• W2028557462 title "Imatinib treatment and Aβ42 in humans" @default.
• W2028557462 cites W1641838791 @default.
• W2028557462 cites W1998593414 @default.
• W2028557462 cites W2013843163 @default.
• W2028557462 cites W2020092689 @default.
• W2028557462 cites W2023652080 @default.
• W2028557462 cites W2030641075 @default.
• W2028557462 cites W2036755018 @default.
• W2028557462 cites W2047110468 @default.
• W2028557462 cites W2056046302 @default.
• W2028557462 cites W2080344984 @default.
• W2028557462 cites W2081881251 @default.
• W2028557462 cites W2085251164 @default.
• W2028557462 cites W2089483984 @default.
• W2028557462 cites W2090150925 @default.
• W2028557462 cites W2090763216 @default.
• W2028557462 cites W2091149521 @default.
• W2028557462 cites W2092198587 @default.
• W2028557462 cites W2103273331 @default.
• W2028557462 cites W2131381632 @default.
• W2028557462 cites W2133019124 @default.
• W2028557462 cites W2140822113 @default.
• W2028557462 cites W2151486690 @default.
• W2028557462 cites W2152583637 @default.
• W2028557462 cites W2156220037 @default.
• W2028557462 cites W2165462380 @default.
• W2028557462 cites W2329648702 @default.
• W2028557462 cites W4211156109 @default.
• W2028557462 doi "https://doi.org/10.1016/j.jalz.2013.08.283" @default.
• W2028557462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24331439" @default.
• W2028557462 hasPublicationYear "2013" @default.
• W2028557462 type Work @default.
• W2028557462 sameAs 2028557462 @default.
• W2028557462 citedByCount "15" @default.
• W2028557462 countsByYear W20285574622014 @default.
• W2028557462 countsByYear W20285574622015 @default.
• W2028557462 countsByYear W20285574622016 @default.
• W2028557462 countsByYear W20285574622017 @default.
• W2028557462 countsByYear W20285574622019 @default.
• W2028557462 countsByYear W20285574622020 @default.
• W2028557462 countsByYear W20285574622021 @default.
• W2028557462 countsByYear W20285574622022 @default.
• W2028557462 countsByYear W20285574622023 @default.
• W2028557462 crossrefType "journal-article" @default.
• W2028557462 hasAuthorship W2028557462A5020185605 @default.
• W2028557462 hasAuthorship W2028557462A5041986125 @default.
• W2028557462 hasAuthorship W2028557462A5063586602 @default.
• W2028557462 hasAuthorship W2028557462A5068342352 @default.
• W2028557462 hasAuthorship W2028557462A5068394264 @default.
• W2028557462 hasAuthorship W2028557462A5079181777 @default.
• W2028557462 hasAuthorship W2028557462A5085816874 @default.
• W2028557462 hasAuthorship W2028557462A5086843415 @default.
• W2028557462 hasAuthorship W2028557462A5091785793 @default.
• W2028557462 hasConcept C104317684 @default.
• W2028557462 hasConcept C126322002 @default.
• W2028557462 hasConcept C145103041 @default.
• W2028557462 hasConcept C202751555 @default.
• W2028557462 hasConcept C2777583451 @default.
• W2028557462 hasConcept C2778729363 @default.
• W2028557462 hasConcept C2779134260 @default.
• W2028557462 hasConcept C28328180 @default.
• W2028557462 hasConcept C31705614 @default.
• W2028557462 hasConcept C502032728 @default.
• W2028557462 hasConcept C502942594 @default.
• W2028557462 hasConcept C54355233 @default.
• W2028557462 hasConcept C71924100 @default.
• W2028557462 hasConcept C86803240 @default.
• W2028557462 hasConcept C95444343 @default.
• W2028557462 hasConcept C98274493 @default.
• W2028557462 hasConceptScore W2028557462C104317684 @default.
• W2028557462 hasConceptScore W2028557462C126322002 @default.
• W2028557462 hasConceptScore W2028557462C145103041 @default.
• W2028557462 hasConceptScore W2028557462C202751555 @default.
• W2028557462 hasConceptScore W2028557462C2777583451 @default.
• W2028557462 hasConceptScore W2028557462C2778729363 @default.
• W2028557462 hasConceptScore W2028557462C2779134260 @default.
• W2028557462 hasConceptScore W2028557462C28328180 @default.
• W2028557462 hasConceptScore W2028557462C31705614 @default.
• W2028557462 hasConceptScore W2028557462C502032728 @default.
• W2028557462 hasConceptScore W2028557462C502942594 @default.
• W2028557462 hasConceptScore W2028557462C54355233 @default.
• W2028557462 hasConceptScore W2028557462C71924100 @default.
• W2028557462 hasConceptScore W2028557462C86803240 @default.
• W2028557462 hasConceptScore W2028557462C95444343 @default.
• W2028557462 hasConceptScore W2028557462C98274493 @default.
• W2028557462 hasFunder F4320309792 @default.
• W2028557462 hasFunder F4320309819 @default.

• next